BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,380,248 | -35.1% | 4,448,000 | -32.2% | 0.06% | -22.7% |
| Q1 2023 | $6,747,850 | +157.5% | 6,561,000 | +166.4% | 0.08% | +167.9% |
| Q4 2022 | $2,620,139 | +55.2% | 2,463,000 | +44.9% | 0.03% | +47.4% |
| Q3 2022 | $1,688,000 | +0.1% | 1,700,000 | 0.0% | 0.02% | -5.0% |
| Q2 2022 | $1,687,000 | -51.9% | 1,700,000 | -51.4% | 0.02% | -45.9% |
| Q1 2022 | $3,507,000 | -18.4% | 3,500,000 | -14.7% | 0.04% | -21.3% |
| Q4 2021 | $4,300,000 | -0.1% | 4,103,000 | -2.3% | 0.05% | -21.7% |
| Q3 2021 | $4,305,000 | -51.2% | 4,198,000 | -50.6% | 0.06% | -49.6% |
| Q2 2021 | $8,829,000 | +1690.9% | 8,500,000 | +1708.5% | 0.12% | +750.0% |
| Q1 2020 | $493,000 | -86.7% | 470,000 | -86.6% | 0.01% | -80.0% |
| Q4 2019 | $3,706,000 | +72.1% | 3,500,000 | +66.7% | 0.07% | +70.7% |
| Q1 2019 | $2,154,000 | -85.4% | 2,100,000 | -85.8% | 0.04% | -69.4% |
| Q4 2018 | $14,754,000 | -26.8% | 14,800,000 | -21.5% | 0.13% | -50.6% |
| Q3 2018 | $20,150,000 | -34.8% | 18,865,000 | -38.1% | 0.27% | -37.3% |
| Q2 2018 | $30,887,000 | +512.6% | 30,500,000 | +515.8% | 0.43% | +476.0% |
| Q3 2017 | $5,042,000 | – | 4,953,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |